文献速递其他结缔组织病

GITRL-mTORC1-GM-CSF正反馈环路促进原发性干燥综合征致病性Th17反应

A GITRL-mTORC1-GM-CSF Positive Loop Promotes Pathogenic Th17 Response in Primary Sjögren Syndrome.
PubMed 文献 · Arthritis Rheumatol · 2024-05-20

研究纳入原发性干燥综合征(pSS)患者与健康对照,检测血清GITRL及Th17相关细胞因子,并进行RNA测序;以非肥胖糖尿病(NOD)小鼠为实验性干燥综合征模型,用重组腺相关病毒(rAAV)转导验证靶向GITRL的体内治疗潜力。结果显示pSS患者血清GITRL显著升高并与白细胞减少、血小板减少、自身抗体、肺部受累及疾病活动度正相关,GITRL通过mTORC1促进致病性Th17反应,靶向GITRL的rAAV可减轻NOD小鼠疾病进展。

要点

  • pSS患者血清GITRL显著升高,与白细胞减少、血小板减少、自身抗体、肺部受累及疾病活动度正相关。
  • GITRL促进Th17及Th17.1细胞扩增,该效应可被GITRL阻断所抑制。
  • 雷帕霉素可有效抑制GITRL诱导的S6和STAT3磷酸化增加及Th17、Th17.1细胞扩增,提示GITRL-mTORC1-GM-CSF正反馈环路。

核心结论

  • 研究识别出GITRL通过GITRL-mTORC1-GM-CSF环路加剧pSS疾病活动并促进致病性Th17反应。
  • 作者认为GITRL可能成为pSS治疗中有前景的靶点。

研究设计与样本

  • 研究纳入pSS患者与健康对照,检测血清GITRL及Th17相关细胞因子,并进行RNA测序以解析关键信号通路。
  • 采用非肥胖糖尿病(NOD)小鼠作为实验性干燥综合征模型,进行重组腺相关病毒(rAAV)转导以验证靶向GITRL的体内治疗潜力。

主要发现

  • pSS患者血清GITRL显著高于对照,并与白细胞减少、血小板减少、自身抗体、肺部受累及疾病活动度呈正相关。
  • 血清GITRL与Th17相关细胞因子相关。
  • GITRL促进Th17及Th17.1细胞扩增。
  • GITRL诱导的粒细胞-巨噬细胞集落刺激因子阳性(GM-CSF+)CD4+ T细胞扩增可被GITRL阻断所抑制。
  • GM-CSF可刺激单核细胞上GITRL的表达。

关键数值与推荐

  • RNA测序提示哺乳动物雷帕霉素靶复合物1(mTORC1)可能是关键调控因子。
  • 雷帕霉素有效抑制GITRL诱导的S6和STAT3磷酸化增加及Th17、Th17.1细胞扩增。
  • 表达靶向GITRL的短发夹RNA的rAAV载体给药可减轻NOD小鼠疾病进展。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Glucocorticoid-induced tumor necrosis factor receptor superfamily-related protein (GITR), with its ligand (GITRL), plays an important role in CD4+ T cell-mediated autoimmunity. This study aimed to investigate the underlying mechanisms of GITRL in primary Sjögren syndrome (pSS). METHODS: Patients with pSS and healthy controls were recruited. Serum GITRL and Th17-related cytokines were determined. RNA sequencing was performed to decipher key signal pathways. Nonobese diabetes (NOD) mice were adopted as experimental Sjögren models and recombinant adeno-associated virus (rAAV) transduction was conducted to verify the therapeutic potentials of targeting GITRL in vivo. RESULTS: Serum GITRL was significantly higher in patients with pSS and showed a positive correlation with leukopenia, thrombocytopenia, autoantibodies, lung involvement, and disease activity. Serum GITRL was correlated with Th17-related cytokines. GITRL promoted the expansion of Th17 and Th17.1 cells. Expansion of granulocyte-macrophage colony-stimulating factor positive (GM-CSF+) CD4+ T cells induced by GITRL could be inhibited by blockade of GITRL. Moreover, GM-CSF could stimulate GITRL expression on monocytes. RNA sequencing revealed mammalian target of rapamycin complexes 1 (mTORC1) might be the key modulator. The increased phosphorylation of S6 and STAT3 and the expansion of Th17 and Th17.1 cells induced by GITRL were effectively inhibited by rapamycin, suggesting a GITRL-mTORC1-GM-CSF positive loop in pathogenic Th17 response in pSS. Administration of an rAAV vector expressing short hairpin RNA targeting GITRL alleviated disease progression in NOD mice. CONCLUSION: Our results identified the pathogenic role of GITRL in exacerbating disease activity and promoting pathogenic Th17 response in pSS through a GITRL-mTORC1-GM-CSF loop. These findings suggest GITRL might be a promising therapeutic target in the treatment of pSS.

来源:Arthritis Rheumatol,查看原文。版权归原作者所有。

引用

  1. Gan Y, Zhou H, Guo Y, et al. A GITRL-mTORC1-GM-CSF Positive Loop Promotes Pathogenic Th17 Response in Primary Sjögren Syndrome. Arthritis Rheumatol. 2024. PMID: 38589318. doi:10.1002/art.42859

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。